Following the success of previous events, SMi's 5th annual conference on Orphan Drugs returns to London this Autumn.
With a focus on the latest regulatory developments and strategies for best route to market, the conference will explore how payers, pharmaceutical, biotech and patient organisations are preparing to participate in and leverage the growing orphan drugs and rare diseases industry. Featured speakers include MHRA, Chiesi Pharma, NICE, Alexion Pharma, Mereo BioPharma, and more.
Registration is now live for this unmissable CPD-certified event.
Early bird rates:
Register by 30th June and save 拢400
Register by 31st August and save 拢200
Register by 30th September and save 拢100
WHY YOU SHOULD ATTEND ORPHAN DRUGS 2016:
Explore the development of orphan drugs and how they prevent, diagnose and treat rare diseases
Understand the industry with a focus on emerging markets and partnering with venture capitals
Discuss the role of patient associations and how they are helping to fund the rare diseases field
Learn strategies on defending the pricing of orphan products and how to establish a foundation for reimbursement
Discover a new business model for developing rare diseases treatments
Panel Discussion: How can multi-stakeholder parnterships improve the orphan drug field
PLUS TWO INTERACTIVE PRE-CONFERENCE WORKSHOPS:
A: Planning for success: Developing the optimal orphan drug development strategy
Hosted by Cell Medica and Chiesi Farmaceutici
B: Paving the way for achieving orphan drug market access
Hosted by RJW & Partners
With a focus on the latest regulatory developments and strategies for best route to market, the conference will explore how payers, pharmaceutical, biotech and patient organisations are preparing to participate in and leverage the growing orphan drugs and rare diseases industry. Featured speakers include MHRA, Chiesi Pharma, NICE, Alexion Pharma, Mereo BioPharma, and more.
Registration is now live for this unmissable CPD-certified event.
Early bird rates:
Register by 30th June and save 拢400
Register by 31st August and save 拢200
Register by 30th September and save 拢100
WHY YOU SHOULD ATTEND ORPHAN DRUGS 2016:
Explore the development of orphan drugs and how they prevent, diagnose and treat rare diseases
Understand the industry with a focus on emerging markets and partnering with venture capitals
Discuss the role of patient associations and how they are helping to fund the rare diseases field
Learn strategies on defending the pricing of orphan products and how to establish a foundation for reimbursement
Discover a new business model for developing rare diseases treatments
Panel Discussion: How can multi-stakeholder parnterships improve the orphan drug field
PLUS TWO INTERACTIVE PRE-CONFERENCE WORKSHOPS:
A: Planning for success: Developing the optimal orphan drug development strategy
Hosted by Cell Medica and Chiesi Farmaceutici
B: Paving the way for achieving orphan drug market access
Hosted by RJW & Partners
